Szu-Wei Cheng

Mr. Szu-Wei Cheng

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2023 in Psychiatry and Clinical Neurosciences
Verified
Journal Article
Open access
SCSzu-Wei Cheng
Szu-Wei Cheng
CCChung‐Wen Chang
Chung‐Wen Chang
WCWan-Jung Chang
Wan-Jung Chang
HWHao‐Wei Wang
Hao‐Wei Wang
CLChih-Sung Liang
Chih-Sung Liang
KSKuan-Pin Su
Kuan-Pin Su
ChatGPT has sparked extensive discussions within the healthcare community since its November 2022 release. However, potential applications in the field of psychiatry have received limited attention. Deep learning has proven beneficial to psychiatry, and GPT is a powerful deep learning‐based language model with immense potential for this field. Despite the convenience of ChatGPT, this advanced chatbot currently has limited practical applications in psychiatry. It may be used to support psychiatrists in routine tasks such as completing medical records, facilitating communications between clinicians and with patients, polishing academic writings and presentations, and programming and performing analyses for research. The current training and application of ChatGPT require using appropriate prompts to maximize appropriate outputs and minimize deleterious inaccuracies and phantom errors. Moreover, future GPT advances that incorporate empathy, emotion recognition, personality assessment, and detection of mental health warning signs are essential for its effective integration into psychiatric care. In the near future, developing a fully‐automated psychotherapy system trained for expert communication (such as psychotherapy verbatim) is conceivable by building on foundational GPT technology. This dream system should integrate practical ‘real world’ inputs and friendly AI user and patient interfaces via clinically validated algorithms, voice comprehension/generation modules, and emotion discrimination algorithms based on facial expressions and physiological inputs from wearable devices. In addition to the technology challenges, we believe it is critical to establish generally accepted ethical standards for applying ChatGPT‐related tools in all mental healthcare environments, including telemedicine and academic/training settings.

26 February 2024 in Psychiatry and Clinical Neurosciences
Verified
Journal Article
Closed access
DLDian-Jeng Li
Dian-Jeng Li
YKYu‐Chen Kao
Yu‐Chen Kao
Shih-Jen TsaiShih-Jen Tsai
Shih-Jen Tsai
Ya-Mei BaiYa-Mei Bai
Ya-Mei Bai
TYTa-Chuan Yeh
Ta-Chuan Yeh
KSKuan-Pin Su
Kuan-Pin Su

6 June 2025 in AI
Verified
Journal Article
Open access
PDF file
Jane Pei-Chen ChangJane Pei-Chen Chang
Jane Pei-Chen Chang
SCSzu-Wei Cheng
Szu-Wei Cheng
SCSteve Ming-Jang Chang
Steve Ming-Jang Chang
KSKuan-Pin Su
Kuan-Pin Su
The rapid adoption of artificial intelligence (AI) within social media platforms has fundamentally transformed the way Generation Z interacts with and navigates the digital landscape. While AI-driven algorithms enhance user experience through content personalization, they can also reinforce biases that affect the mental health and overall well-being of young individuals. This review delves into the intersections of AI bias, social medial engagement, and youth mental health, with a particular focus on how algorithmic decision-making influences exposure to harmful content, intensifies social comparison and spreads digital misinformation. By addressing these aspects, this article highlights both the risks and opportunities presented by AI-powered social media. It also advocates for evidence-based strategies to mitigate the harms associated with algorithmic bias, urging collaboration among AI developers, mental health experts, policymakers and educators at personal, community (school), and national and international levels to cultivate a safer, more supportive digital ecosystem for future generations.

Verified
Journal Article
Open access
PDF file
Daniel Tzu-Li ChenDaniel Tzu-Li Chen
Daniel Tzu-Li Chen
SCSzu-Wei Cheng
Szu-Wei Cheng
TCTiffany Chen
Tiffany Chen
Jane Pei-Chen ChangJane Pei-Chen Chang
Jane Pei-Chen Chang
Bing-Fang HwangBing-Fang Hwang
Bing-Fang Hwang
KSKuan-Pin Su
Kuan-Pin Su
Background and Objectives: Nicotinamide adenine dinucleotide (NAD) is an important coenzyme in various physiological processes, including sirtuins (SIRTs) and kynurenine pathway (KP). Previous studies have shown that lower NAD levels can be indicative of increased risks of cancer and psychiatric disorders. However, there has been no prior study exploring the link between NAD homeostasis and psychiatric disorders from a genetic perspective. Therefore, we aimed to investigate the association of genetic polymorphism in the pathways of NAD biosynthesis with major depressive disorder (MDD). Methods: A total of 317 patients were included in the case group and were compared with sex-matched control group of 1268 participants (1:4 ratio) from Taiwan Biobank (TWB). All subjects in the control group were over 65 years old, which is well past the average age of onset of MDD. Genomic DNA extracted from patients’ blood buffy coat was analyzed using the Affymetrix TWB array. Full-model tests were conducted for the analysis of single nucleotide polymorphism (SNPs) in all candidate genes. We focused on genes within the NAD-related candidate pathways, including 15 in KP, 12 in nicotinate metabolism, 7 in SIRTs, and 19 in aldehyde dehydrogenases (ALDHs). A total of 508 SNPs were analyzed in this study. After significant SNPs were determined, 5000 genome-wide max(T) permutations were performed in Plink. Finally, we built a predictive model with logistic regression and assessed the interactions of SNPs with the haplotype association tests. Results: We found three SNPs that were significantly associated with MDD in our NAD-related candidate pathways, one within the KP (rs12622574 in ACMSD) and two within the nicotinate metabolism (rs28532698 in BST1 and rs3733593 in CD38). The observed association with MDD was significant in the dominant model of inheritance with marital status, education level, and body mass index (BMI) adjusted as covariates. Lastly, in haplotype analysis, the three associated SNPs consisted of one haploblock in ACMSD, four haploblocks in BST1, and two haploblocks in CD38. Conclusions: This study provides the first evidence that genetic variations involved in NAD homeostasis in the KP and nicotinate metabolism may be associated with the occurrence of MDD.

Verified
Journal Article
Open access
PDF file
SCSzu-Wei Cheng
Szu-Wei Cheng
JLJing-Xing Li
Jing-Xing Li
Daniel Tzu-Li ChenDaniel Tzu-Li Chen
Daniel Tzu-Li Chen
YCYu-Chuan Chien
Yu-Chuan Chien
Jane Pei-Chen ChangJane Pei-Chen Chang
Jane Pei-Chen Chang
KSKuan-Pin Su
Kuan-Pin Su
Importance: The high incidence of major depressive episodes during interferon-α (IFN-α) therapy is considered the most powerful supportive evidence for the inflammation theory of depression. As the kynurenine pathway plays an important role connecting inflammation and depression, it is plausible to investigate this pathway for predictive genetic markers for IFN-α-induced depression. Methods: In this prospective case-control study, we assessed 291 patients with chronic hepatitis C viral infection taking IFN-α therapy and analyzed the single nucleotide polymorphisms (SNPs) in genes in the kynurenine pathway. Our case group contained patients who developed IFN-α-induced depression during the treatment, and others were defined as the control group. Genomic DNA was extracted from leukocytes in the peripheral blood and analyzed by Affymetrix TWB array. We first tested allelic, dominant, and recessive models on each of our SNPs using Fisher’s exact test. We then conducted 5000 gene-wide max(T) permutations based on the best model of each SNP to provide strong gene-wide family-wise error rate control. Finally, we preformed logistic regression for the significant SNPs acquired in previous procedures, with sex and education level as covariates to build predictive models. Additional haplotype analyses were conducted with Haploview 4.2 to investigate the combining effect of multiple significant SNPs within a gene. Results: With sex and education level as covariates, rs8082252 (p = 0.0015, odds ratio = 2.716), rs8082142 (p = 0.0031, odds ratio = 2.499) in arylformamidase (AFMID), and rs12477181 (p = 0.0004, odds ratio = 0.3478) in kynureninase (KYNU) were significant in logistic regression models with dominant modes of inheritance. Haplotype analyses showed the two significant SNPs in AFMID to be in the same haploblock and highly correlated (r2 = 0.99). There were two significant haplotypes (by the sequence of rs8082252, rs8082142): AT (χ2 = 7.734, p = 0.0054) and GC (χ2 = 6.874, p = 0.0087). Conclusions: This study provided supportive evidence of the involvement of the kynurenine pathway in IFN-α-induced depression. SNPs in this pathway were also predictive of this disease.